(Q43721782)

English

A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

Golub LM

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Nungavarm S. Ramamurthy

2

object named as

Ramamurthy NS

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Llavaneras A

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Heikkilä P

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Teronen O

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Salo T

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Rifkin BR

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ryan ME

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sorsa T

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Journal of Periodontology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1069-1077

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Periodontal diseases: epidemiology

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Host response assessment in recurring periodontitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate).

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Bisphosphonates: preclinical aspects and use in osteoporosis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

L-Selectin--a signalling receptor for lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Modulation of bone resorption by tetracyclines.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

MMP inhibition and downregulation by bisphosphonates.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Purification and characterization of a collagenase extracted from rabbit tumours

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

An interleukin 1 like factor stimulates bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Clinical importance of metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

The effect of lipopolysaccharide from bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase release

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Regulation of osteoclast function

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Effects of Tetracyclines on Bone Metabolism

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2001.72.8.1069

21 January 2018

Identifiers

10.1902/JOP.2001.72.8.1069

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43721782&oldid=2102833094"